Janssen, Taiwan University To Co-Develop HBV Drugs Seeking Cure
This article was originally published in PharmAsia News
Executive Summary
Janssen Pharmaceuticals and National Taiwan University have agreed to research and co-develop drugs for treating hepatitis B, a disease that remains incurable.